VRTX vs REGN
VRTX 与 REGN 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | VRTXVERTEX PHARMACEUTICALS INC / MA | REGNREGENERON PHARMACEUTICALS, INC. |
|---|---|---|
| 市值 | $130.87B | — |
| 市盈率(TTM) | 30.1 | 19.5 |
| 市净率 | 6.46 | — |
| 市销率 | 10.9x | — |
| 营收 | $12.59B(TTM) | $15.53B(TTM) |
| 营收同比增长 | 8.9% | 1.0% |
| 净利润 | $4.41B(TTM) | $4.33B(TTM) |
| 净利同比增长 | 838.1% | 2.1% |
| 每股收益(稀释) | $17.17(TTM) | $40.41(TTM) |
| 息税前利润率 | 34.8% | 24.9% |
| 净资产收益率 | 19.5% | 14.2% |
| 投入资本回报率 | 25.0% | 9.4% |
| 一年总回报 | +33.5% | +34.8% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:VRTX vs REGN
| 指标 | VRTX | REGN |
|---|---|---|
| 期末价值 | $62.9K | $20.3K |
| 总回报 | +528.6% | +103.3% |
| 年化收益 (CAGR) | +19.5% | +7.1% |
| 波动率 | 32.7% | 32.0% |
| 夏普比率 | 0.58 | 0.25 |
| 索提诺比率 | 0.86 | 0.36 |
| 最大回撤 | -41.6% | -59.7% |
基于 2600 个共同交易日,2016-05-16 → 2026-09-17 · 无风险利率 4.12%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)